Form 4: Agilent Technologies Executive Henrik Ancher-Jensen Reports Stock and Option Transactions
SEC Form 4 Filing
Agilent Technologies Senior Vice President Henrik Ancher-Jensen acquired 4,336 shares of common stock and 12,517 stock options on November 27, 2024.
Summary
- Henrik Ancher-Jensen, a Senior Vice President at Agilent Technologies, reported the acquisition of 4,336 shares of common stock at a price of $138.14 per share on November 27, 2024.
- These shares were granted as Restricted Stock Units under the company's 2018 Stock Plan and vest in four equal annual installments starting November 27, 2024, with a one-year post-vest holding period.
- Additionally, Mr. Ancher-Jensen acquired 12,517 employee stock options, also at a price of $138.14, on the same date.
- These options are exercisable in four equal annual installments beginning on November 27, 2025, and expire on November 27, 2034.
- Following these transactions, Mr. Ancher-Jensen directly owns 90,674.2842 shares of Agilent Technologies common stock.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices, which is generally viewed positively as it aligns executive interests with company performance. There are no negative implications.
Positives
- The acquisition of stock and options by a senior executive could be seen as a positive sign of confidence in the company's future performance.
- The vesting schedule of the restricted stock units and options encourages long-term commitment from the executive.
Industry Context
This filing is a routine disclosure of stock and option transactions by a company executive, which is common practice in publicly traded companies. It provides transparency into executive compensation and ownership.
Comparison to Industry Standards
- Stock option and restricted stock unit grants are a standard form of compensation for executives in publicly traded technology companies like Agilent Technologies.
- The vesting schedules and holding periods are typical for such grants, designed to align executive interests with long-term shareholder value.
- Companies like Thermo Fisher Scientific and Danaher also use similar equity-based compensation plans for their executives.
Stakeholder Impact
- The stock and option grants may have a minor positive impact on shareholder sentiment, as it indicates executive confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 11/27/2024 | Date of the stock and option transactions, and the first vesting date for the restricted stock units. |
| 11/27/2025 | First vesting date for the employee stock options. |
| 11/27/2034 | Expiration date for the employee stock options. |
| 12/02/2024 | Date the Form 4 was signed. |
Keywords
Agilent Technologies, stock options, restricted stock units, insider trading, executive compensation, equity securities, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.